A Phase Ib Open-Label, Multi-center Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia (BO43243)

Principal Investigator

Dr Toby Eyre

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1003988